Synchronous co‑expression of Id‑1 and nuclear NF‑κB p65 promotes cervical cancer progression and malignancy, and is associated with a poor prognosis and chemosensitivity

Wu,Zhao; Li,Jinke; Zhang,Yi; Hu,Lina; Peng,Xue

doi:10.3892/or.2019.7301

Synchronous co‑expression of Id‑1 and nuclear NF‑κB p65 promotes cervical cancer progression and malignancy, and is associated with a poor prognosis and chemosensitivity

Authors:
- Zhao Wu
- Jinke Li
- Yi Zhang
- Lina Hu
- Xue Peng
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China, Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan 610041, P.R. China, Department of Obstetrics and Gynecology, Second Affiliated Hospital, Chongqing Medical University, Chongqing 410010, P.R. China
Published online on: September 5, 2019 https://doi.org/10.3892/or.2019.7301
Pages: 2075-2086

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Although inhibitor of differentiation 1 (Id‑1) and NF‑κB have been shown have play a role in tumorigenesis, their mechanisms and exact roles in cervical cancer have not yet been addressed. This study aimed to investigate the clinical significance of Id‑1 and NF‑κB p65 in cervical cancer and to elucidate their roles in malignant properties. Paraffin‑embedded cervical tissue specimens (n=85) were collected for immunohistochemistry and survival analysis. Targeting Id‑1 with lentivirus in vitro allowed the examination of the NF‑κB signaling pathway and cell survival. The results demonstrated the elevated co‑expression of Id‑1 and nuclear NF‑κB p65 was more frequently associated with aggressive cervical cancer behavior and poorer clinical outcomes. Targeting Id‑1 with short hairpin RNA or Id‑1 overexpression lentivirus in SiHa cells demonstrated that Id‑1 is associated with nuclear NF‑κB p65 expression and cell survival capacity. The physical interaction between Id‑1 and NF‑κB p65 was validated in SiHa cells. Moreover, the survival‑promoting or chemoresistant effects of Id‑1 may be attributed to the subsequent activation of NF‑κB signaling. On the whole, the synchronous co‑expression of Id‑1 and nuclear NF‑κB p65 has a prominent role in cervical cancer, suggesting a combined analysis of Id‑1 and NF‑κB may help to predict malignant properties and prognosis. Aside from NF‑κB, Id‑1 may also be developed as a promising therapeutic strategy for cervical cancer.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
2	Fernandes JV, DE Medeiros Fernandes TA, DE Azevedo JC, Cobucci RN, DE Carvalho MG, Andrade VS and DE Araújo JM: Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review). Oncol Lett. 9:1015–1026. 2015. View Article : Google Scholar : PubMed/NCBI
3	Perk J, Iavarone A and Benezra R: Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer. 5:603–614. 2005. View Article : Google Scholar : PubMed/NCBI
4	Wong YC, Wang X and Ling MT: Id-1 expression and cell survival. Apoptosis. 9:279–289. 2004. View Article : Google Scholar : PubMed/NCBI
5	Han S, Gou C, Hong L, Liu J, ZheyiHa n, Liu C, Wang J, Wu K, Ding J and Fan D: Expression and significances of Id1 helix-loop-helix protein overexpression in gastric cancer. Cancer Lett. 216:63–71. 2004. View Article : Google Scholar : PubMed/NCBI
6	Cho Y, Cho EJ, Lee JH, Yu SJ, Kim YJ, Kim CY and Yoon JH: Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells. Biomed Pharmacother. 83:607–616. 2016. View Article : Google Scholar : PubMed/NCBI
7	Jang KS, Han HX, Paik SS, Brown PH and Kong G: Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer. Cancer Lett. 244:203–210. 2006. View Article : Google Scholar : PubMed/NCBI
8	Zielinski AJ, Fong S, Allison J, Kawahara M, Coppe JP, Feiler H, Lee NM and Desprez PY: The helix-loop-helix Id-1 inhibits PSA expression in prostate cancer cells. Int J Cancer. 126:2490–2496. 2010.PubMed/NCBI
9	Li J, Jia H, Xie L, Wang X, He H, Lin Y and Hu L: Correlation of inhibitor of differentiation 1 expression to tumor progression, poor differentiation and aggressive behaviors in cervical carcinoma. Gynecol Oncol. 114:89–93. 2009. View Article : Google Scholar : PubMed/NCBI
10	Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and Ben-Neriah Y: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 431:461–466. 2004. View Article : Google Scholar : PubMed/NCBI
11	Karin M: Nuclear factor-kappaB in cancer development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
12	Chandrika G, Natesh K, Ranade D, Chugh A and Shastry P: Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFKB and PKC-α signaling. Sci Rep. 6:224552016. View Article : Google Scholar : PubMed/NCBI
13	Li J, Jia H, Xie L, Wang X, Wang X, He H, Lin Y and Hu L: Association of constitutive nuclear factor-kappaB activation with aggressive aspects and poor prognosis in cervical cancer. Int J Gynecol Cancer. 19:1421–1426. 2009. View Article : Google Scholar : PubMed/NCBI
14	Peng X, Wu Z, Yu L, Li J, Xu W, Chan HC, Zhang Y and Hu L: Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with human cervical cancer malignancy, progression and prognosis. Gynecol Oncol. 125:470–476. 2012. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Hao L, Liao Q, Tang Q, Deng H and Chen L: Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway. Biochem Biophys Res Commun. 470:643–649. 2016. View Article : Google Scholar : PubMed/NCBI
17	Shuno Y, Tsuno NH, Okaji Y, Tsuchiya T, Sakurai D, Nishikawa T, Yoshikawa N, Sasaki K, Hongo K, Tsurita G, et al: Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer. J Surg Res. 161:76–82. 2010. View Article : Google Scholar : PubMed/NCBI
18	Forootan SS, Wong YC, Dodson A, Wang X, Lin K, Smith PH, Foster CS and Ke Y: Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer. Hum Pathol. 38:1321–1329. 2007. View Article : Google Scholar : PubMed/NCBI
19	Sun W, Guo MM, Han P, Lin JZ, Liang FY, Tan GM, Li HB, Zeng M and Huang XM: Id-1 and the p65 subunit of NF-KB promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis. Carcinogenesis. 33:810–817. 2012. View Article : Google Scholar : PubMed/NCBI
20	Su Y, Gao L, Teng L, Wang Y, Cui J, Peng S and Fu S: Id1 enhances human ovarian cancer endothelial progenitor cell angiogenesis via PI3K/Akt and NF-KB/MMP-2 signaling pathways. J Transl Med. 11:1322013. View Article : Google Scholar : PubMed/NCBI
21	Tsai CH, Yang MH, Hung AC, Wu SC, Chiu WC, Hou MF, Tyan YC, Wang YM and Yuan SF: Identification of Id1 as a downstream effector for arsenic-promoted angiogenesis via PI3K/Akt, NF-KB and NOS signaling. Toxicol Res (Camb). 5:151–159. 2015. View Article : Google Scholar : PubMed/NCBI
22	Shin CH and Choi DS: Essential roles for the Non-canonical IKB kinases in linking inflammation to cancer, obesity, and diabetes. Cells. 8(pii): E1782019. View Article : Google Scholar : PubMed/NCBI
23	Li J, Li Y, Wang B, Ma Y and Chen P: Id-1 promotes migration and invasion of non-small cell lung cancer cells through activating NF-KB signaling pathway. J Biomed Sci. 24:952017. View Article : Google Scholar : PubMed/NCBI
24	Li B, Cheung PY, Wang X, Tsao SW, Ling MT, Wong YC and Cheung AL: Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells. Carcinogenesis. 28:2313–2320. 2007. View Article : Google Scholar : PubMed/NCBI
25	Porquet N, Poirier A, Houle F, Pin AL, Gout S, Tremblay PL, Paquet ER, Klinck R, Auger FA and Huot J: Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFKB survival axis downstream of Death receptor-3. BMC Cancer. 11:2852011. View Article : Google Scholar : PubMed/NCBI
26	Ma H, Wei Y, Leng Y, Li S, Gao L, Hu H, Chen L, Wang F, Xiao H, Zhu C and Liang C: TGF-β1-induced expression of Id-1 is associated with tumor progression in gastric cancer. Med Oncol. 31:192014. View Article : Google Scholar : PubMed/NCBI
27	Roschger C and Cabrele C: The Id-protein family in developmental and cancer-associated pathways. Cell Commun Signal. 15:72017. View Article : Google Scholar : PubMed/NCBI
28	Ma J, Shi M, Li G, Wang N, Wei J, Wang T, Ma J and Wang Y: Regulation of Id1 expression by epigallocatechin-3-gallate and its effect on the proliferation and apoptosis of poorly differentiated AGS gastric cancer cells. Int J Oncol. 43:1052–1058. 2013. View Article : Google Scholar : PubMed/NCBI
29	Lin J, Guan Z, Wang C, Feng L, Zheng Y, Caicedo E, Bearth E, Peng JR, Gaffney P and Ondrey FG: Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res. 16:77–87. 2010. View Article : Google Scholar : PubMed/NCBI
30	Li B, Tsao SW, Li YY, Wang X, Ling MT, Wong YC, He QY and Cheung AL: Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Int J Cancer. 125:2576–2585. 2009. View Article : Google Scholar : PubMed/NCBI
31	Yang Y, Liou HC and Sun XH: Id1 potentiates NF-kappaB activation upon T cell receptor signaling. J Biol Chem. 281:34989–34996. 2006. View Article : Google Scholar : PubMed/NCBI
32	Thulasidasan AKT, Retnakumari AP, Shankar M, Vijayakurup V, Anwar S, Thankachan S, Pillai KS, Pillai JJ, Nandan CD, Alex VV, et al: Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy. Oncotarget. 8:107374–107389. 2017. View Article : Google Scholar : PubMed/NCBI